Samalin Investment Counsel, LLC Glaukos Corp Transaction History

Samalin Investment Counsel, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $3,067 - $5,611	-88 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$40.27 - $56.99 $483 - $683	-12 Reduced 12.0%	88 $3.89 Million
Q2 2021 Aug 12, 2021	BUY	$73.06 - $97.7 $7,306 - $9,770	100 New	100 $8,000
Q1 2021 May 11, 2021	SELL	$70.43 - $97.42 $7,043 - $9,742	-100 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$37.23 - $50.97 $3,722 - $5,097	100 New	100 $4,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.